06/16/2021 | Press release | Distributed by Public on 06/16/2021 14:06
June 16, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
We have read Item 4.01 of Vitality Biopharma Inc.'s Form 8-K dated June 16, 2021, and agree with the statements made in Item 4.01(a). We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Weinberg & Company, P.A.
Los Angeles, California